Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions

Journal of Virology

Volumn 89, Issue 3, 2015, Pages 1579-1586

  Boon, Siaw Shi ^a   Tomaić, Vjekoslav ^a   Thomas, Miranda ^a   Roberts, Sally ^b   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PDZ PROTEIN; PROTEIN E6; PROTEIN KINASE B; ONCOPROTEIN; PROTEIN BINDING; PROTEIN KINASE; VIRUS PROTEIN;

ALPHAPAPILLOMAVIRUS; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 58; IN VITRO STUDY; NONHUMAN; PROTEIN PROTEIN INTERACTION; COMPARATIVE STUDY; HOST PATHOGEN INTERACTION; METABOLISM; PAPILLOMAVIRIDAE; PDZ DOMAIN; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENE PROTEINS; PAPILLOMAVIRIDAE; PDZ DOMAINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; VIRAL PROTEINS;

EID: 84921520264     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01961-14     Document Type: Article

References (37)

1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens-part B: biological agents. Lancet Oncol 10:321-322. http://dx.doi.org/10.1016/S1470-2045(09)70096-8.
2. de Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27. http://dx.doi.org/10.1016/j.virol.2004.03.033.
3. Mantovani F, Banks L. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887. http://dx.doi.org/10.1038/sj.onc.1204869.
4. Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898. http://dx.doi.org/10.1038/sj.onc.1204860.
5. Lee SS, Weiss RS, Javier RT. 1997. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94:6670-6675. http://dx.doi.org/10.1073/pnas.94.13.6670.
6. Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH, Crompton A, Chan AC, Anderson JM, Cantley LC. 1997. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275:73-77. http://dx.doi.org/10.1126/science.275.5296.73.
7. Gardiol D, Kühne C, Glaunsinger B, Lee SS, Javier R, Banks L. 1999. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18:5487-5496. http://dx.doi.org/10.1038/sj.onc.1202920.
8. Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M. 1997. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A 94:11612-11616. http://dx.doi.org/10.1073/pnas.94.21.11612.
9. Nakagawa S, Huibregtse JM. 2000. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol 20:8244-8253. http://dx.doi.org/10.1128/MCB.20.21.8244-8253.2000.
10. Thomas M, Massimi P, Navarro C, Borg JP, Banks L. 2005. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 24:6222-6230. http://dx.doi.org/10.1038/sj.onc.1208757.
11. Banks L, Pim D, Thomas M. 2012. Human tumour viruses and the deregulation of cell polarity in cancer. Nat Rev Cancer 12:877-886. http://dx.doi.org/10.1038/nrc3400.
12. Spanos WC, Hoover A, Harris GF, Wu S, Strand GL, Anderson ME, Klingelhutz AJ, Hendriks W, Bossler AD, Lee JH. 2008. The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J Virol 82:2493-2500. http://dx.doi.org/10.1128/JVI.02188-07.
13. Spanos WC, Geiger J, Anderson ME, Harris GF, Bossler AD, Smith RB, Klingelhutz AJ, Lee JH. 2008. Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells. Head Neck 30:139-147. http://dx.doi.org/10.1002/hed.20673.
14. Watson RA, Thomas M, Banks L, Roberts S. 2003. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J Cell Sci 116:4925-4934. http://dx.doi.org/10.1242/jcs.00809.
15. Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF. 2003. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol 77:6957-6964. http://dx.doi.org/10.1128/JVI.77.12.6957-6964.2003.
16. Shai A, Brake T, Somoza C, Lambert PF. 2007. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 67:1626-1635. http://dx.doi.org/10.1158/0008-5472.CAN-06-3344.
17. Lee C, Laimins LA. 2004. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol 78:12366-12377. http://dx.doi.org/10.1128/JVI.78.22.12366-12377.2004.
18. Delury CP, Marsh EK, James CD, Boon SS, Banks L, Knight GL, Roberts S. 2013. The role of protein kinase A regulation of the E6 PDZbinding domain during the differentiation-dependent life cycle of human papillomavirus type 18. J Virol 87:9463-9472. http://dx.doi.org/10.1128/JVI.01234-13.
19. Brimer N, Vande Pol SB. 2014. Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal HPV genome maintenance. J Virol 88:3027-3030. http://dx.doi.org/10.1128/JVI.02360-13.
20. Nicolaides L, Davy C, Raj K, Kranjec C, Banks L, Doorbar J. 2011. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance. Virology 414:137-145. http://dx.doi.org/10.1016/j.virol.2011.03.017.
21. Lorenz LD, Rivera Cardona J, Lambert PF. 2013. Inactivation of p53 rescues the maintenance of high risk HPV DNA genomes deficient in expression of E6. PLoS Pathog 9:e1003717. http://dx.doi.org/10.1371/journal.ppat.1003717.
22. Narayan N, Massimi P, Banks L. 2009. CDK phosphorylation of the discs large tumour suppressor controls its localisation and stability. J Cell Sci 122:65-74. http://dx.doi.org/10.1242/jcs.024554.
23. Boon SS, Banks L. 2013. High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner. J Virol 87:1586-1595. http://dx.doi.org/10.1128/JVI.02074-12.
24. Narayan N, Subbaiah VK, Banks L. 2009. The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg. Virology 387:1-4. http://dx.doi.org/10.1016/j.virol.2009.02.030.
25. Kühne C, Gardiol D, Guarnaccia C, Amenitsch H, Banks L. 2000. Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6. Oncogene 19:5884-5891. http://dx.doi.org/10.1038/sj.onc.1203988.
26. Muslin AJ, Tanner JW, Allen PM, Shaw AS. 1996. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84:889-897. http://dx.doi.org/10.1016/S0092-8674(00)81067-3.
27. Oh S, Shin S, Lightfoot SA, Janknecht R. 2013. 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer. Cancer Res 73:5110-5119. http://dx.doi.org/10.1158/0008-5472.CAN-13-0578.
28. Reinhardt HC, Yaffe MB. 2013. Phospho-Ser/Thr-binding domains: navigating the cell cycle andDNAdamage response. Nat Rev Mol Cell Biol 14:563-580. http://dx.doi.org/10.1038/nrm3640.
29. Aitken A. 2006. 14-3-3 proteins: a historic overview. Semin Cancer Biol 16:162-172. http://dx.doi.org/10.1016/j.semcancer.2006.03.005.
30. Wigler M, Pellicer A, Silverstein S, Axel R, Urlaub G, Chasin L. 1979. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A 76:1373-1376. http://dx.doi.org/10.1073/pnas.76.3.1373.
31. Nagasaka K, Pim D, Massimi P, Thomas M, Tomaić V, Subbaiah VK, Kranjeć C, Nakagawa S, Yano T, Taketani Y, Myers M, Banks L. 2010. The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene 29:5311-5321. http://dx.doi.org/10.1038/onc.2010.265.
32. Pim D, Thomas M, Javier R, Gardiol D, Banks L. 2000. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19:719-725. http://dx.doi.org/10.1038/sj.onc.1203374.
33. Thomas M, Massimi P, Banks L. 1996. HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence. Oncogene 13:471-480.
34. Glaunsinger BA, Lee SS, Thomas M, Banks L, Javier R. 2000. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and highrisk papillomavirus E6 oncoproteins. Oncogene 19:5270-5280. http://dx.doi.org/10.1038/sj.onc.1203906.
35. Zhang Y, Dasgupta J, Ma RZ, Banks L, Thomas M, Chen XS. 2007. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a highrisk HPV oncoprotein. J Virol 81:3618-3626. http://dx.doi.org/10.1128/JVI.02044-06.
36. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M. 2010. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3:ra3. http://dx.doi.org/10.1126/scisignal.2000475.
37. Obata T, Yaffe MB, Leparc GG, Piro ET, Maegawa H, Kashiwagi A, Kikkawa R, Cantley LC. 2000. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J Biol Chem 275:36108-36115. http://dx.doi.org/10.1074/jbc.M005497200.